ClinicalTrials.gg
CompletedNCT05987878Updated Aug 14, 2023

Single Minimal Conjunctival Incision for Strabismus

An observational study in Strabismus, Comitant, sponsored by Universidad Autonoma de Madrid. Completed at 1 site in Spain. Open to participants aged 6 Years to 60 Years. Per ClinicalTrials.gov, last updated 2023-08-14.

Sponsored by Universidad Autonoma de Madrid · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
25
Ages
6 Years to 60 Years
Sex
All
01

Study summary

The purpose of this investigation is to study the feasibility and inflammatory response of surgery for rectus muscles using a small single bulbar conjunctival incision posterior and parallel to the muscle insertion.

Patients requiring surgery of at least one rectus muscle with several diagnoses, operated under general or topical / sub-Tenon's anesthesia, who had no previous eye muscle surgery, will be recruited. Routinary clinical ophthalmological examination will be carried out. After applying a 5-0 PGA traction suture, a 3-4 mm single conjunctival incision posterior and parallel to the rectus muscle insertion will be done. A hang-back recession with 6-0 PGA suture will be carried out, and the conjunctiva closed by an 8-0 PGA single stitch. The main outcome measure will be duration of swelling and hemorrhage, and secondary outcome measure will be motor outcome at 2 months after surgery.

Read the detailed description

Purpose/Background: To study the feasibility and inflammatory response of surgery for rectus muscles using a small single bulbar conjunctival incision posterior and parallel to the muscle insertion.

Methods: Patients requiring surgery of at least one rectus muscle with several diagnoses, operated under general or topical / sub-Tenon's anesthesia, who had no previous eye muscle surgery, are included. Routinary clinical ophthalmological examination is carried out. After applying a 5-0 PGA traction suture, a 3-4 mm single conjunctival incision posterior and parallel to the rectus muscle insertion will be done. A hang-back recession with 6-0 PGA suture will be carried out, and the conjunctiva closed by an 8-0 PGA single stitch. The main outcome measure is duration of swelling and hemorrhage, and secondary outcome measure is motor outcome at 2 months after surgery. Results are compared with retrospectively collected data of patients operated using limbal (n= 20) and fornix incision (n= 21) as a point of reference.

02

Conditions studied

  • Strabismus, Comitant

Browse trials for

03

In context

Strabismus

142 studies on the registry are indexed under Strabismus; 31 are open to participants now.

This study's enrollment of 25 is below the median of 96 across 54 observational studies indexed under Strabismus.

Browse Strabismus studies →

Lead sponsor

Universidad Autonoma de Madrid is the lead sponsor of 51 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 60 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

25 subjects who required surgery of rectus muscle in comitant strabismus

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • patients requiring surgery of at least one rectus muscle with several diagnoses, operated under general or topical / sub-Tenon's anesthesia

Exclusion criteria

Exclusion Criteria:

  • patients had no previous eye muscle surgery
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
25 participants (actual)
Patient registry
No

Interventions

  • Proceduresingle minimal conjunctival incision

    A 5-0 PGA traction suture was used near the corneal limbus corresponding to the operated muscle. A 3-4 mm single conjunctival incision posterior and parallel to the insertion in medial, lateral or superior rectus muscle was used. A hang-back recession of the muscle was done using 6-0 PGA suture. The conjunctiva was closed by an 8-0 PGA single stitch with knot burial

06

What researchers measure

Primary outcomes

  1. Duration of conjunctival swelling/hemorrhage

    Evaluate duration of conjunctival swelling/hemorrhage

    Time frame: 2 months

Secondary outcomes

  1. Motor outcome at 2 months after surgery (by Prism and Alternate Cover Test)

    Evaluate motor status at 2 months after surgery

    Time frame: 2 months

07

Study locations

1 site
  • UAM
    Madrid, 28029, Spain
08

References and documents

Individual participant data

Plan to share: Undecided — Data shared when solicited to the PI

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2021 to primary completion in Mar 2023, 25 months.

Of 26 observational studies under Strabismus, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 50. This study's 25 months is close to that.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 26, 2023
First posted
Aug 14, 2023
StartActual
Jan 31, 2021
Primary completionActual
Mar 1, 2023
CompletionActual
May 1, 2023
Last update
Aug 14, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 14, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05987878
Lead sponsor
Universidad Autonoma de Madrid
Responsible party
Jaime Tejedor (Principal Investigator, Universidad Autonoma de Madrid) — Principal investigator
First posted
Aug 14, 2023
Start date
Jan 31, 2021
Primary completion
Mar 1, 2023
Completion
May 1, 2023
Last update
Aug 14, 2023

Study contacts

Jaime Tejedor, MD, PhD
principal investigator · Universite Abdou Moumouni de Niamey, Niger

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion